Vyome Holdings, Inc. (HIND)
2.20
+0.03
(+1.38%)
USD |
NASDAQ |
Sep 02, 16:00
2.20
0.00 (0.00%)
After-Hours: 19:31
Vyome Holdings Research and Development Expense (TTM) : 1.591M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.591M |
| March 31, 2026 | 1.164M |
| December 31, 2025 | 0.5883M |
| September 30, 2025 | 0.2775M |
| June 30, 2025 | 0.3047M |
| March 31, 2025 | 0.6236M |
| December 31, 2024 | 1.017M |
| September 30, 2024 | 1.689M |
| June 30, 2024 | 2.164M |
| March 31, 2024 | 2.346M |
| December 31, 2023 | 2.315M |
| September 30, 2023 | 2.017M |
| June 30, 2023 | 2.058M |
| March 31, 2023 | 2.224M |
| December 31, 2022 | 2.516M |
| September 30, 2022 | 2.352M |
| June 30, 2022 | 3.34M |
| March 31, 2022 | 2.696M |
| December 31, 2021 | 2.522M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.124M |
| June 30, 2021 | 2.412M |
| March 31, 2021 | 2.774M |
| December 31, 2020 | 3.46M |
| September 30, 2020 | 4.073M |
| June 30, 2020 | 4.388M |
| March 31, 2020 | 5.341M |
| December 31, 2019 | 6.523M |
| September 30, 2019 | 7.369M |
| June 30, 2019 | 8.563M |
| March 31, 2019 | 10.50M |
| December 31, 2018 | 10.70M |
| September 30, 2018 | 11.05M |
| June 30, 2018 | 11.48M |
| March 31, 2018 | 10.89M |
| December 31, 2017 | 10.65M |
| September 30, 2017 | 10.56M |
| June 30, 2017 | 9.934M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cardiac Biotech Solutions, Inc. | -- |
| Anika Therapeutics, Inc. | 27.45M |
| Enovis Corp. | 124.32M |
| Edwards Lifesciences Corp. | 1.091B |
| Perspective Therapeutics, Inc. | 82.13M |